Patent details

EP3569711 Title: LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3569711
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP19180844.3
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
15/12/2015
Grant date:
03/02/2021
EP Publication Date:
20/11/2019
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
18/02/2021
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
03/02/2021
EP B1 Publication Date:
03/02/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/12/2035
Lapsed By Expiration Date:
Patent Validated Date:
13/03/2021
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
03/02/2021
 
 

 

Name:
Dicerna Pharmaceuticals, Inc.
Address:
33, Hayden Avenue, Lexington, MA 02421, United States of America (US)

Agent

Name:
dr. A. Krebs
From:
12/03/2021
Address:
HGF B.V. Benoordenhoutseweg 46, 2596 BC, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
BROWN, Bob, Dale
Address:
Littleton, MA 01460, United States of America (US)

2

Name:
WANG, Weimin
Address:
Lexington, MA 02421, United States of America (US)

Priority

1

Priority Patent Number:
201562187848 P
Priority Date:
02/07/2015
Priority Country:
United States of America (US)

2

Priority Patent Number:
201562187856 P
Priority Date:
02/07/2015
Priority Country:
United States of America (US)

3

Priority Patent Number:
201462092238 P
Priority Date:
15/12/2014
Priority Country:
United States of America (US)

4

Priority Patent Number:
201462092241 P
Priority Date:
15/12/2014
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C07H 1/00; C07H 21/04; C07H 99/00; C12N 15/11; C12N 15/113; A61K 47/54;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
11/21
Publication date:
17/03/2021
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
05/21
Publication date:
03/02/2021
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202110
Publication date:
10/03/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202105
Publication date:
03/02/2021
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/12/2025
Annual Fee Number:
11
Annual Fee Amount:
500 Euro
Last Annual Payment Date:
21/11/2024
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
400 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
12/03/2021 Outgoing Correspondence Letter no formal defects 1 PDF /0/9/3/9/4/0800649390/docs/ep19180844.3_1_399582l271.pdf
18/02/2021 Claims First filed claims 4 PDF /0/9/3/9/4/0800649390/docs/ep19180844.3_0_claims20210218151951558.pdf